Prognostic variables in patients with upper urinary tract cancers

International Journal of Clinical Oncology

Volumn 1, Issue 3, 1996, Pages 135-138

  Miyake, Hideaki ^a   Hara, Isao ^a   Fujisawa, Masato ^a   Eto, Hiroshi ^a   Okada, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Grade; Stage; Upper urinary tract cancer; Vascular invasion

Indexed keywords

EID: 0008918877     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02348378     Document Type: Article

References (20)

1. Batata M, Grabstald H. Upper tract urothelial tumors. Urol Clin North Amer 1976;3:79-82.
2. Cummings KB. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Amer 1980;7:569-578.
3. Murphy DM, Zinke H, Furlow WL. Primary Grade 1 transitional cell carcinoma of the renal pelvis and ureter. J Urol 1980;123:629-634.
4. Huben RP, Mounzer AM, Murphy GP.Tumor grade and stage as prognostic variables in upper tract urotherial tumors. Cancer 1988;62:2016-2020.
5. Akaza H, Koiso K, Niijima T. Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer 1987;59:1369-1375.
6. Davis BW, Hough AJ, Gradner WA. Renal pelvic carcinoma: morphological correlates of metastatic behavior. J Urol 1987;137:857-861.
7. Reitelman C, Sawczuk IS, Olsson CA, Puchner PJ, Benson MC. Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J Urol 1987;138:1144-1145.
8. Oldbring J, Glifberg I, Mikulowski P, Hellsten S. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol 1989;141:1311-1313.
9. Das AK, Carson CC, Bolick D, Paulson DF. Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 1990;66:1919-1923.
10. Fujimoto H,Tobisu K, Sakamoto M, Kamiya M, Kakizoe T. Intraductal tumor involvement and renal parenchymal invasion of transitional cell carcinoma in the renal pelvis. J Urol 1995;153:57-60.
11. Oldbring J, Hellsten S, Lindholm K, Mikulowski P, Tribukait B. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter. Cancer 1989;64:2141-2145.
12. Hasui Y, Nishi S, Kitada S, Osada Y, Asada Y.The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma. J Urol 1992;148:1783-1785.
13. The Japanese Urological Association, Japanese Pathological Society. General rules for clinical and pathological studies on renal pelvic and ureteral cancer. Tokyo: Kanehara, 1992 (in Japanese).
14. McDonald JR, Priestley JT. Carcinoma of renal pelvis: histopathologic study of seventy-five cases with special reference to prognosis. J Urol 1944;51:245-259.
15. Barber BR, Sommers SC, Rotterdam H, Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obst Gynec 1978;52:343-349.
16. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ari G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988-61:1018-1023.
17. Gabbert HE, Meier S, Gerharz CD, Hommel G. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 1991;49:203-210.
18. Okumura A, Yokoyama T, Muraishi Y, Nagakawa O, Sakamoto M, Kazama T, Fuse H, Katayama T. Clinical study on renal pelvic and ureteral tumors. Acta Urol Jpn 1994;40:777-780 (in Japanese).
19. Sternberg CN,Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Celler N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985;133:403-107.
20. Logothetics CJ.The role of chemotherapy in the management of invasive bladder cancer. Eur Urol 1988;14:19-23.